Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Bayer Healthcare

The European Society for Medical Oncology (ESMO) wishes to thank Bayer HealthCare Pharmaceuticals for supporting this section on Dermatological Side Effects of Multikinase Inhibitors.

Medical writing support was provided by Mark English, PhD and Nadina Grosios, PhD, MPH of COR2Ed GmbH.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings